对于PTSD的MDMA辅助心理治疗:随机对照试验的系统审查
Barbara Brett1, Christine Bynum1
1Psychology Department, Colorado State University - Pueblo, Pueblo, CO, USA.
Journal of psychoactive drugs
|November 5, 2025
概括
在治疗创伤后应激障碍 (PTSD) 方面,MDMA辅助心理治疗 (MDMA-AT) 显著有前途,大多数参与者在治疗后不再符合标准. 需要进一步的研究才能获得FDA的批准.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 创伤后应激障碍 (PTSD) 是一种慢性精神健康状况,有效治疗方法有限.
- 3,4-甲基二氧化甲甲胺 (MDMA) 辅助心理治疗 (MDMA-AT) 在临床试验中已经显示出减轻PTSD症状的潜力.
- 美国食品和药物管理局最近投票反对推MDMA-AT,这凸显了人们对其风险效益概况的持续担忧.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估MDMA-AT在患有PTSD的成年人中的安全性和有效性.
- 评估当前的证据基础,以告知潜在的FDA批准MDMA-AT.
- 综合有关PTSD症状减轻和治疗耐受性的研究结果.
主要方法:
- 对7项随机对照试验 (RCT) 的系统审查,涉及280名患有PTSD的成年参与者.
- 独立的数据审查,重点关注PTSD症状减少和安全结果.
- 从分析中排除了两个收回的文章.
主要成果:
- 在六项疗效研究中的五项 (83.3%) 报告MDMA-AT与安慰剂相比显著改善了PTSD症状.
- 在治疗后,41.7%-85.7%接受MDMA-AT的参与者不再符合PTSD标准,而安慰剂组为25.0%-33.3%.
- 参与者通常可以很好地容忍MDMA-AT治疗.
结论:
- 用MDMA辅助心理治疗 (MDMA-AT) 显示出对PTSD症状的可行治疗的潜力.
- 来自RCT的证据支持MDMA-AT的疗效和安全性.
- 建议在严格的道德监督下进行额外的研究,以指导FDA批准决策.
更多相关视频
相关概念视频
Modeling in Therapy
370
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
370
Post-traumatic Stress Disorder
469
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
469
Therapeutic Drug Monitoring: Affecting Factors
193
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
193
Interpersonal Psychotherapy
295
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
295
Electroconvulsive Therapy
841
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
841


